Study: Mantle Cell Lymphoma Patients Respond to CAR-T Cell Therapy
CAR-T cell therapy has shown to be a viable treatment for mantle cell lymphoma after being studied at the University of Texas MD Anderson Cancer Center. The study showed that…
source: pixabay.com
How Immunotherapies are Being Used for the Treatment of Mantle Cell Lymphoma
Mantle cell lymphoma is a cancer that often responds well to initial treatment. Because of this, doctors often recommend intense treatment soon after diagnosis. While it is often successful, sometimes…
source: pixabay.com
CAR T-Cell Therapy Could Soon be Available for Mantle Cell Lymphoma
According to a story from The ASCO Post, the promising results from a phase II clinical trial conducted last year suggests that CAR T-cell therapy could be an effective treatment…
.jpg)
FDA Grants Orphan Drug Designation to Cellectar’s CLR 131 for the Sixth Time
The biopharmaceutical company Cellectar Biosciences recently announced that the FDA granted its lead phospholipid drug conjugate, CLR 131, Orphan Drug Designation(ODD) for treatment of lymphoplasmacytic lymphoma. ODD is granted by…
source: pixabay.com
A New CAR-T Cell Therapy for Mantle Cell Lymphoma Could be on Its Way
According to a story from Targeted Oncology, the results of a recent clinical trial have left drug developers Kite and Gilead with the confidence to proceed with regulatory approval from…
.jpg)
Is the FDA Approving Drugs too Quickly?
At times there seems to be no happy medium in life. A recent article in Bloomberg claims that the speed at which the FDA is approving newly developed drugs is…
source: pixabay.com
CAR-T Cell Therapies are Improving Treatment for Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) is a very rare form of cancer, and oncologists may only see a few cases of it through the course of their careers. Because of…
source: pixabay.com
A Treatment for Mantle Cell Lymphoma gets Cleared Under FDA Accelerated Approval
According to a story from BioSpace, the biopharmaceutical company BeiGene Co., Ltd has recently announced that its drug zanubrutinib (marketed as BRUKINSA) has earned Accelerated Approval from the US Food…
<a href="https://pixabay.com/users/PublicDomainPictures/">PublicDomainPictures</a> / Pixabay
The Latest Trends in Mantle Cell Lymphoma Treatment
According to an article from journals.lww.com, the treatment of mantle cell lymphoma, a rare type of blood cancer, has historically been a significant medical challenge. However, recent developments in the…
New Target Identified to Treat Acute Myeloid Leukemia and Mantle Cell Lymphoma
Mantle cell lymphoma (MCL) and acute myeloid leukemia (AML) are two rare forms of blood cancer with a high unmet need. The majority of cases in these patient populations are…
<a href="https://pixabay.com/users/Parentingupstream/">Parentingupstream</a> / Pixabay
Clinical Trial Results With Velcade in Mantle Cell Lymphoma Inspire Continued Research
According to a story from curetoday.com, a recent Phase 2 trial has demonstrated that bortezomib (marketed as Velcade) has the potential to be an effective therapy for patients with mantle…
Source: Pixabay.com
A New Combination of Therapies has Potential to Treat all Mantle Cell Lymphoma Patients
Mantle cell lymphoma is caused by a genetic mutation which produces cancerous white blood cells. Of course, these are the cells which fight infection in a normal body. Therefore in…
<a href="https://pixabay.com/users/freegr/">freegr</a> / Pixabay
This Treatment is Giving Mantle Cell Lymphoma Patients Another Chance
According to a story from the Sydney Morning Herald, Maxwell Hayes thought that is cancer was gone after an eight year period of remission. Then, his mantle cell lymphoma returned.…
<a href="https://pixabay.com/users/PixelAnarchy/">PixelAnarchy</a> / Pixabay
Mantle Cell Lymphoma Patients in Western Australia Will Get Much Cheaper Access to Essential Treatment
According to a story from news.com.au, patients in Western Australia will start getting much cheaper access to a highly valuable treatment next month for a rare form of cancer called…
<a href="https://pixabay.com/users/kermy/">kermy</a> / Pixabay
A New Drug May Slow Cell Growth in Mantle Cell Lymphoma
Researchers have discovered a new drug that appears to slow cell growth in mantle cell lymphoma. The full article can be read here, at the Bellvitge Biomedical Research Institute (IDIBELL)…
source: pixabay.com
Combination Treatment is Dramatically Improving Outcomes for Mantle Cell Lymphoma Patients
According to a story from adc.net.au, an innovative new cancer treatment regimen is responsible for doubling survival rates for patients with certain types of rare, difficult-to-treat blood cancers. This combination…
source: pixabay.com
Novartis and Harvard Are Teaming up to Develop New Immunotherapy Technology
According to a story from biopharmadive.com, the Swiss pharmaceutical company Novartis has entered a partnership with researchers from the engineering and applied sciences school at Harvard University. The team will…
source: pixabay.com
The Leukemia and Lymphoma Society Just Picked Up New Funding For Research
According to an article from prnewswire.com, the Leukemia and Lymphoma Society (LLS) obtained new funding for cancer research thanks to a donation from The Sarah Cannon Fund, which is part…
Source: pixabay.com
Early Treatment is Essential for Fighting Back Against Relapsed Mantle Cell Lymphoma
According to a December 9th press release from Janssen Biotech, Inc, the results of a pooled analysis of patients with mantle cell lymphoma illustrated that those treated with Imbruvica (ibrutinib) had…
Source: Pixabay
FDA Approves Mantle Cell Lymphoma Treatment
Good news for mantle cell lymphoma patients! A new treatment called Calquence has just received approval from the U.S. Food and Drug Administration (FDA) for adults who suffer from this rare…
Source: Pixabay
FDA Gives New Hope for Those Fighting Mantle Cell Lymphoma
A recent report from the Food & Drug Administration reveals renewed efforts for the treatment of one of the rarest forms of non-Hodgkin's Lymphoma, Mantle Cell Lymphoma. Due to promising advancement…
Source: Pixabay
Don’t Forget World Lymphoma Awareness Day NEXT WEEK!
September is National Blood Cancer Awareness Month and September 15th is World Lymphoma Awareness Day. To find out more, check out the Lymphoma Research Foundation (LRF). Not only does this…
Source: Pixabay
Researchers Determined to Find Allusive Mantle Cell Lymphoma Cure
Mantle Cell Lymphoma (MCL) is a very rare cancer of the blood. So rare in fact, that there are only 4,200 cases diagnosed in the U.S. each year and…
Source: Pixabay
Groundbreaking FDA Approval for This Cancer Gene Therapy
Little Emily Whitehead is looking attentively at a butterfly that has landed on her finger. She coos at it and lets it rest on the tip of her thumb peacefully.…
[[Source: pixabay.com]
Mayweather Ain’t Got Nothing on This Cancer-Fighting Combo
According to a press release on Newswise, there's a one-two punch that could save the lives of thousands of people living with drug resistant rare cancers. Researchers at UC San Diego…
- 1
- 2
